One can review the legal processes of electroCore, Inc. which is a commercial stage bioelectronic medicine company, focused on developing non-invasive vagus nerve stimulation therapy (nVNS) platform. nVNS is a platform for bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems. The Company is providing gammaCore device for the treatment of cluster headache, drug induced headache and migraine, the acute treatment of migraine and episodic cluster headache. They have FDA approval per headaches and device is on the market.